568 related articles for article (PubMed ID: 11085348)
1. Comparative tolerability of treatments for inflammatory bowel disease.
Stein RB; Hanauer SB
Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in inflammatory bowel disease.
Pierik M; Rutgeerts P; Vlietinck R; Vermeire S
World J Gastroenterol; 2006 Jun; 12(23):3657-67. PubMed ID: 16773681
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of long-term treatment with 5-aminosalicylic acid.
Patel H; Barr A; Jeejeebhoy KN
Can J Gastroenterol; 2009 Mar; 23(3):170-6. PubMed ID: 19319380
[TBL] [Abstract][Full Text] [Related]
4. Drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):105-112. PubMed ID: 37418329
[No Abstract] [Full Text] [Related]
5. Combination treatment of inflammatory bowel disease: Present status and future perspectives.
Triantafillidis JK; Zografos CG; Konstadoulakis MM; Papalois AE
World J Gastroenterol; 2024 Apr; 30(15):2068-2080. PubMed ID: 38681984
[TBL] [Abstract][Full Text] [Related]
6. Expanded table: Some drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e115-e119. PubMed ID: 37418332
[No Abstract] [Full Text] [Related]
7. Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response.
Simpson JB; Sekela JJ; Carry BS; Beaty V; Patel S; Redinbo MR
Gut Microbes; 2023; 15(1):2203963. PubMed ID: 37122075
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: perioperative pharmacological considerations.
Kumar A; Auron M; Aneja A; Mohr F; Jain A; Shen B
Mayo Clin Proc; 2011 Aug; 86(8):748-57. PubMed ID: 21803957
[TBL] [Abstract][Full Text] [Related]
9. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?
van Bodegraven AA; Mulder CJ
World J Gastroenterol; 2006 Oct; 12(38):6115-23. PubMed ID: 17036381
[TBL] [Abstract][Full Text] [Related]
10. Table: safety of drugs for IBD in pregnancy.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e113. PubMed ID: 37418330
[No Abstract] [Full Text] [Related]
11. Potential for developing purinergic drugs for gastrointestinal diseases.
Ochoa-Cortes F; Liñán-Rico A; Jacobson KA; Christofi FL
Inflamm Bowel Dis; 2014 Jul; 20(7):1259-87. PubMed ID: 24859298
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis.
Lima SF; Pires S; Rupert A; Oguntunmibi S; Jin WB; Marderstein A; Funez-dePagnier G; Maldarelli G; Viladomiu M; Putzel G; Yang W; Tran N; Xiang G; Grier A; Guo CJ; Lukin D; Mandl LA; Scherl EJ; Longman RS
Cell Rep Med; 2024 Mar; 5(3):101431. PubMed ID: 38378002
[TBL] [Abstract][Full Text] [Related]
13. Table: Some drug interactions with drugs for IBD.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e114. PubMed ID: 37418331
[No Abstract] [Full Text] [Related]
14. Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease.
Park B; Han G; Jin DY; Gil KC; Shin D; Lee J; Park JY; Jang H; Park D; Lee S; Kim K; Yang Y; Kim Y; Kim JS; Kim SH; Shim MK
ACS Nano; 2024 Jun; 18(25):16297-16311. PubMed ID: 38867457
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids in inflammatory bowel disease: Are they still a therapeutic option?
Quera R; Núñez P; Sicilia B; Flores L; Gomollón F
Gastroenterol Hepatol; 2023 Nov; 46(9):716-726. PubMed ID: 36375697
[TBL] [Abstract][Full Text] [Related]
16. IBD in women of reproductive age: where do novel therapies fit in?
Cuffe M; Selinger CP
Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):129-131. PubMed ID: 38507228
[No Abstract] [Full Text] [Related]
17. Drug-Induced Acute Pancreatitis After Long-Term Sulfasalazine Therapy.
Mehershahi S; Haider A; Shaikh D; Abbas H; Ihimoyan A
Cureus; 2020 Sep; 12(9):e10441. PubMed ID: 33072451
[TBL] [Abstract][Full Text] [Related]
18. Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG; Rutgeerts P; Sands BE; Hanauer S; Colombel JF; Sandborn WJ; Van Assche G; Axler J; Kim HJ; Danese S; Fox I; Milch C; Sankoh S; Wyant T; Xu J; Parikh A;
N Engl J Med; 2013 Aug; 369(8):699-710. PubMed ID: 23964932
[TBL] [Abstract][Full Text] [Related]
19. [Adverse effects of sulfasalazine: discussion of mechanism and role of sulfonamide structure].
Atheymen R; Affes H; Ksouda K; Mnif L; Sahnoun Z; Tahri N; Zeghal KM; Hammami S
Therapie; 2013; 68(6):369-73. PubMed ID: 24356188
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
